Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review
Elekta AB (Elekta) is a medical technology company engaged in developing advanced clinical solutions, comprehensive information systems and offering services for the management of brain disorders and improved cancer care. It principally operates under three divisions, namely, Elekta Neuroscience, which provides integrated solutions for stereotactic radio-surgery and minimally invasive neurosurgery; Elekta Oncology, which provides clinical solutions for radiation therapy; and Elekta Software, which provides integrated treatment planning, information and workflow management systems. The company’s products are used in treating cancer with radio therapy and in diagnosing and treating brain disorders in more than 5,000 hospitals worldwide. Elekta principally operates in the regions of North America, Europe, Asia and Japan. The company is headquartered in Stockholm, Sweden.
Elekta AB Key Recent Developments…
Jul 20, 2011: Findings On Use Of Elekta SBRT To Treat Early Stage NSCLC Presented At Lung Cancer Conference Jul 18, 2011: Latest Releases Of XiO Planning And Focal Contouring Systems To Increase Efficiency In Planning Therapy: Elekta Jun 09, 2011: Elekta Reports Net Sales Of SEK7.9 Billion In Fiscal Year Ended 2011 Apr 08, 2011: Elekta Emphasizes Advantages Of Leksell Gamma Knife Perfexion Over Competing Systems At 2011 AANS Meeting Mar 15, 2011: Nottingham University Hospital Uses Elekta's Electronic Medical Record Workspace For Image Guided Radiation Therapy
This comprehensive SWOT profile of Elekta AB provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Section 1 - About the Company 6 Elekta AB - Key Facts 6 Elekta AB - Key Employees 7 Elekta AB - Key Employee Biographies 8 Elekta AB - Major Products and Services 9 Elekta AB - Medical Equipment Pipeline Products Data 12 Elekta AB Pipeline Products by Equipment Type 12 Elekta AB - History 13 Elekta AB - Company Statement 16 Elekta AB - Locations And Subsidiaries 17 Head Office 17 Other Locations & Subsidiaries 17 Elekta AB - Key Manufacturing Facilities 20 Section 2 – Company Analysis 21 Elekta AB - Business Description 21 Business Description - Treatment for Cancer and Brain disorders 21 Treatment for Cancer and Brain disorders - Overview 21 Treatment for Cancer and Brain disorders - Financials 22 Treatment for Cancer and Brain disorders - Market View 22 Treatment for Cancer and Brain disorders - Technology 22 Elekta AB - Corporate Strategy 23 Elekta AB - SWOT Analysis 24 SWOT Analysis - Overview 24 Elekta AB - Strengths 24 Strength - Geographical Diversity 24 Strength - Strong Liquidity Position 24 Strength - Comprehensive Product and Service Portfolio 24 Strength - Financial Performance 25 Strength - Industry Recognitions 25 Elekta AB - Weaknesses 25 Weakness - Product Recalls 25 Elekta AB - Opportunities 26 Opportunity - Inorganic Growth Strategy 26 Opportunity - Huge Potential in Emerging Markets 26 Opportunity - Growing Cancer Market 26 Opportunity - Strategic Agreements 26 Opportunity - Regulatory Approvals and New Product Launches 27 Elekta AB - Threats 27 Threat - Rapid Technological Changes 27 Threat - Government Regulations 27 Threat - Intense Competition 27 Threat - Alternative Therapies 28 Threat - Industry Consolidation Challenges 28 Elekta AB - Key Competitors 29 Section 3 – Company Financial Ratios 30 Financial Ratios - Capital Market Ratios 30 Financial Ratios - Annual Ratios 30 Performance Chart 32 Financial Performance 32 Financial Ratios - Interim Ratios 33 Financial Ratios - Ratio Charts 34 Section 4 – Company’s Lifesciences Financial Deals and Alliances 35 Elekta AB, Medical Equipment, Deals By Year, 2005 to YTD 2011 35 Elekta AB, Medical Equipment, Deals By Type, 2005 to YTD 2011 36 Elekta AB, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011 37 Elekta AB, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011 38 Elekta AB, Recent Deals Summary 39 Section 5 – Company’s Recent Developments 40 Jul 20, 2011: Findings On Use Of Elekta SBRT To Treat Early Stage NSCLC Presented At Lung Cancer Conference 40 Jul 18, 2011: Latest Releases Of XiO Planning And Focal Contouring Systems To Increase Efficiency In Planning Therapy: Elekta 40 Jun 09, 2011: Elekta Reports Net Sales Of SEK7.9 Billion In Fiscal Year Ended 2011 41 Apr 08, 2011: Elekta Emphasizes Advantages Of Leksell Gamma Knife Perfexion Over Competing Systems At 2011 AANS Meeting 42 Mar 15, 2011: Nottingham University Hospital Uses Elekta's Electronic Medical Record Workspace For Image Guided Radiation Therapy 43 Mar 08, 2011: Elekta Reports Net Income Of SEK195m In Q3 Fiscal Year Ended 2011 43 Dec 08, 2010: Elekta Reports Net Sales Of SEK1.9 Billion In Q2 Fiscal Year Ended 2011 44 Nov 02, 2010: Elekta Presents Solutions For Ultimate Precision In Cancer Care At ASTRO Investor Meeting 44 Oct 28, 2010: Elekta Highlights Full Spectrum Of Cancer Management Solutions At 2010 ASTRO 45 Sep 08, 2010: Elekta Reports Net Income Of SEK103 Million In Q1 Fiscal 2011 46 Section 6 – Appendix 48 Methodology 48 Ratio Definitions 48 About GlobalData 52 Contact Us 52 Disclaimer 52 List of Tables Elekta AB, Key Facts 6 Elekta AB, Key Employees 7 Elekta AB, Key Employee Biographies 8 Elekta AB, Major Products and Services 9 Elekta AB Number of Pipeline Products by Equipment Type 12 Elekta AB Pipeline Products by Equipment Type 12 Elekta AB, History 13 Elekta AB, Other Locations 17 Elekta AB, Subsidiaries 18 Elekta AB, Key Manufacturing Facilities 20 Elekta AB, Key Competitors 29 Elekta AB, Ratios based on current share price 30 Elekta AB, Annual Ratios 30 Elekta AB, Interim Ratios 33 Elekta AB, Medical Equipment, Deals By Year, 2005 to YTD 2011 35 Elekta AB, Medical Equipment, Deals By Type, 2005 to YTD 2011 36 Elekta AB, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011 37 Elekta AB, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011 38 Elekta AB, Recent Deals Summary 39 Currency Codes 48 Capital Market Ratios 48 Equity Ratios 49 Profitability Ratios 49 Cost Ratios 50 Liquidity Ratios 50 Leverage Ratios 51 Efficiency Ratios 51 List of Figures Elekta AB Pipeline Products by Equipment Type 12 Elekta AB, Performance Chart (2007 - 2011) 32 Elekta AB, Ratio Charts 34 Elekta AB, Medical Equipment, Deals By Year, 2005 to YTD 2011 35 Elekta AB, Medical Equipment, Deals by Type, 2005 to YTD 2011 36 Elekta AB, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011 37 Elekta AB, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011 38
3DM Inc. - Strategic SWOT Analysis ReviewSummary3DM Inc. (3DM) is a privately held specialty biomaterials and medical device company. It is a subsidiary of 3D-Matrix, Ltd, Japan. The company develops ...Read More
3M Health Care - Strategic SWOT Analysis ReviewSummary3M Health Care, a business segment of 3M Company, provides medical and oral care products, drug delivery and health information systems worldwide. ...Read More
Summary3SBio Inc. (3S Bio) is a biotechnology company with focus on the research and development, manufacturing and marketing of biopharmaceutical products in China. It develops recombinant, or geneti ...Read More
3Shape A/S. Market Share AnalysisSummaryGlobalData’s new report, “3Shape A/S. Market Share Analysis” provides in-depth information on 3Shape A/S.’s market position in the CAD/CAM dental system ...Read More
3WIN nv - Product Pipeline AnalysisSummary3WIN nv (3WIN) is engaged in the development and marketing of active implantable medical devices. The company is developing a deep brain stimulator (DBS), whi ...Read More
4SC AG (VSC) - Financial and Strategic SWOT Analysis ReviewSummary4SC AG is a Germany based research oriented company which concentrates mainly on the discovery of the drugs as well as its development ...Read More
SummaryA&G Pharmaceutical, Inc. (A&G) is a pharmaceutical company, based in the US. The company develops therapeutic and diagnostic products for the in-vitro diagnostic markets. Its products include b ...Read More
A-dec Inc. GmbH Market Share AnalysisSummaryGlobalData’s new report, “A-dec Inc. GmbH Market Share Analysis” provides in-depth information on A-dec Inc..’s market position in the dental device ...Read More
For support please contact: US Toll Free
+1 888-789-6604 Asia Pacific
To receive alerts about an update, future offers and discounts on this report, signup here. Email ID